A detailed history of Sofinnova Investments, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 1,550,280 shares of NTRA stock, worth $260 Million. This represents 18.64% of its overall portfolio holdings.

Number of Shares
1,550,280
Previous 1,550,280 -0.0%
Holding current value
$260 Million
Previous $168 Million 17.37%
% of portfolio
18.64%
Previous 9.31%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$37.55 - $62.64 $58.2 Million - $97.1 Million
-1,550,280 Reduced 50.0%
1,550,280 $97.1 Million
Q4 2022

Feb 13, 2023

SELL
$34.17 - $47.91 $82,008 - $114,983
-2,400 Reduced 0.08%
3,100,560 $125 Million
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $240,408 - $303,264
2,400 Added 0.08%
3,102,960 $346 Million
Q1 2018

May 15, 2018

BUY
$9.0 - $11.95 $27.9 Million - $37.1 Million
3,100,560 New
3,100,560 $28.7 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.